Industry and press criticism gives CDRH (Center for Devices and Radiological Health) a turbulent year
This article was originally published in Clinica
Executive Summary
In its relations with its regulated industries, the US FDA is Required to strike a balance between the need for vigilance and the Possibility that too much regulation will stifle innovation. At least, that's the theory.